✦ LIBER ✦

P-012 Clonal activation of Akt in low-risk MDS patients with del(5q) treated with lenalidomide

✍ Scribed by Follo, M.Y.; Mongiorgi, S.; Clissa, C.; Stoyanova, M.; Paolini, S.; Quaranta, M.; Martinelli, G.; Manzoli, L.; Cocco, C.; Finelli, C.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

P-104 Outcomes by IPSS-R in lenalidomide

✍ Sekeres, M.; Swern, A.; Fenaux, P.; Greenberg, P.; Sanz, G.; Bennett, J.; Dreyfu 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 399 KB

P-011 TP53 mutations in low-risk MDS pat

✍ Belickova, M.; Vesela, J.; Cermak, J.; Dostalova, M.M.; Krejcik, Z.; Stara, E.; 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 84 KB

Extended survival and reduced risk of AM

✍ List, A F; Bennett, J M; Sekeres, M A; Skikne, B; Fu, T; Shammo, J M; Nimer, S D 📂 Article 📅 2013 🏛 Nature Publishing Group 🌐 English ⚖ 440 KB

P-313 Response and progression rate of p

✍ Germing, U.; Giagounidis, A.; Büsche, G.; Platzbecker, U.; Götze, K.; Nolte, F.; 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 65 KB

Cytogenetic and molecular predictors of

✍ Yuka Sugimoto; Mikkael A Sekeres; Hideki Makishima; Fabiola Traina; Valeria Visc 📂 Article 📅 2012 🏛 BioMed Central 🌐 English ⚖ 262 KB

Patients with del(5q) MDS who fail to ac

✍ Gudrun Göhring; Aristoteles Giagounidis; Guntram Büsche; Hans Heinrich Kreipe; M 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 280 KB